Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Khanna, Savita ^a   Biswas, Sabyasachi ^a   Shang, Yingli ^a   Collard, Eric ^a   Azad, Ali ^a   Kauh, Courtney ^a   Bhasker, Vineet ^a   Gordillo, Gayle M ^a   Sen, Chandan K ^a   Roy, Sashwati ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; WOUND HEALING; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; HOMOZYGOTE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; SKIN;

MUS;

ADULT; ANIMALS; APOPTOSIS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; FAS LIGAND PROTEIN; FEMALE; HOMOZYGOTE; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MIDDLE AGED; OXIDATIVE STRESS; SKIN; WOUND HEALING;

EID: 77949681013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009539     Document Type: Article

References (80)

1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, et al. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382-387.
2. Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes.[comment]. Journal of Clinical Investigation 117: 1219-1222.
3. Pierce GF (2001) Inflammation in nonhealing diabetic wounds: the space-time continuum does matter.[comment]. American Journal of Pathology 159: 399-403.
4. Gillitzer R, Goebeler M (2001) Chemokines in cutaneous wound healing. Journal of Leukocyte Biology 69: 513-521.
5. Martin P (1997) Wound healing-aiming for perfect skin regeneration. Science 276: 75-81.
6. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. American Journal of Pathology 170: 1178-1191.
7. Abrass CK, Hori M (1984) Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats. J Immunol 133: 1307-1312.
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue.[see comment]. Journal of Clinical Investigation 112: 1796-1808.
9. Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, et al. (2007) Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. Journal of Investigative Dermatology 127: 2259-2267.
10. Singer AJ, Clark RA (1999) Cutaneous wound healing. New England Journal of Medicine 341: 738-746.
11. Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. American Journal of Pathology 146: 56-66.
12. Meszaros AJ, Reichner JS, Albina JE (1999) Macrophage phagocytosis of wound neutrophils. J Leukoc Biol 65: 35-42.
13. deCathelineau AM, Henson PM (2003) The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays in Biochemistry 39: 105-117.
14. Gardai SJ, Bratton DL, Ogden CA, Henson PM (2006) Recognition ligands on apoptotic cells: a perspective. Journal of Leukocyte Biology 79: 896-903.
15. Vandivier RW, Henson PM, Douglas IS (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129: 1673-1682.
16. Erwig LP, Henson PM (2007) Clearance of apoptotic cells by phagocytes. Cell Death Differ Epub ahead of print.
17. Fadok VA (1999) Clearance: the last and often forgotten stage of apoptosis. J Mammary Gland Biol Neoplasia 4: 203-211.
18. Rosen A, Casciola-Rosen L (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6: 6-12.
19. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, et al. (1999) Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406.
20. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, et al. (2005) The antioxidant function of the p53 tumor suppressor.[see comment]. Nature Medicine 11: 1306-1313.
21. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology & Medicine 11: 81-128.
22. Breyer MD, Bottinger E, Brosius FC, 3rd, Coffman TM, Harris RC, et al. (2005) Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45.
23. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology 127: 514-525.
24. Verhoven B, Schlegel RA, Williamson P (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. Journal of Experimental Medicine 182: 1597-1601.
25. Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, et al. (1997) Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. Journal of Experimental Medicine 185: 1511-1516.
26. Matsue H, Kobayashi H, Hosokawa T, Akitaya T, Ohkawara A (1995) Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Archives of Dermatological Research 287: 315-320.
27. Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, et al. (1987) Impairment of monocyte "lectin-like" receptor activity in type 1 (insulin-dependent) diabetic patients. Diabetologia 30: 228-231.
28. Glass EJ, Stewart J, Weir DM (1986) Altered immune function in alloxan-induced diabetes in mice. Clin Exp Immunol 65: 614-621.
29. Wheat LJ (1980) Infection and diabetes mellitus. Diabetes Care 3: 187-197.
30. O'Brien BA, Fieldus WE, Field CJ, Finegood DT (2002) Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats. Cell Death & Differentiation 9: 457-464.
31. Liu BF, Miyata S, Kojima H, Uriuhara A, Kusunoki H, et al. (1999) Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 48: 2074-2082.
32. Maree AF, Komba M, Dyck C, Labecki M, Finegood DT, et al. (2005) Quantifying macrophage defects in type 1 diabetes. Journal of Theoretical Biology 233: 533-551.
33. Darby IA, Bisucci T, Hewitson TD, MacLellan DG (1997) Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. International Journal of Biochemistry & Cell Biology 29: 191-200.
34. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
35. Sudo C, Ogawara H, Saleh AW, Nishimoto N, Utsugi T, et al. (2007) Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus. Lab Hematol 13: 108-112.
36. Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, et al. (2009) High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and {beta}-cell apoptosis. FASEB J.
37. Bouma G, Nikolic T, Coppens JM, van Helden-Meeuwsen CG, Leenen PJ, et al. (2005) NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. European Journal of Immunology 35: 225-235.
38. Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, et al. (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103: 27-37.
39. Sullivan SR, Underwood RA, Gibran NS, Sigle RO, Usui ML, et al. (2004) Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg 113: 953-960.
40. Trousdale RK, Jacobs S, Simhaee DA, Wu JK, Lustbader JW (2009) Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. J Surg Res 151: 100-107.
41. Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153: 1127-1128.
42. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
43. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH (2004) Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65: 116-128.
44. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiological Reviews 83: 835-870.
45. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683-765.
46. Liechty KW, Kim HB, Adzick NS, Crombleholme TM (2000) Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. Journal of Pediatric Surgery 35: 866-872; discussion 872-863.
47. Lundberg JE, Roth TP, Dunn RM, Doyle JW (1998) Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue. Archives of Dermatological Research 290: 669-673.
48. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. Journal of Investigative Dermatology 115: 245-253.
49. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, et al. (1996) Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8: 548-556.
50. Cooper L, Johnson C, Burslem F, Martin P (2005) Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice. Genome Biology 6: R5.
51. Peters T, Sindrilaru A, Hinz B, Hinrichs R, Menke A, et al. (2005) Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO Journal 24: 3400-3410.
52. Cohen JJ (1991) Programmed cell death in the immune system. Advances in Immunology 50: 55-85.
53. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. Journal of Experimental Medicine 184: 429-440.
54. Haslett C (1992) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 83: 639-648.
55. Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2: 787-795.
56. Savill J (2000) Apoptosis in resolution of inflammation. Kidney Blood Press Res 23: 173-174.
57. Manfredi AA, Iannacone M, D'Auria F, Rovere-Querini P (2002) The disposal of dying cells in living tissues. Apoptosis 7: 153-161.
58. Ren Y, Savill J (1998) Apoptosis: the importance of being eaten. Cell Death Differ 5: 563-568.
59. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Reviews Immunology 2: 965-975.
60. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898.
61. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
62. Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. Journal of Clinical Investigation 109: 41-50.
63. Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. Journal of Experimental Medicine 176: 287-292.
64. Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. Journal of Immunology 181: 3733-3739.
65. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clinical & Experimental Immunology 142: 481-489.
66. Michlewska S, Dransfield I, Megson IL, Rossi AG (2009) Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB Journal 23: 844-854.
67. Bystrom J, Evans I, Newson J, Stables M, Toor I, et al. (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
68. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, et al. (2002) Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284-33290.
69. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK (2006) Dermal wound healing is subject to redox control. Mol Ther 13: 211-220.
70. Roy S, Khanna S, Rink C, Biswas S, Sen CK (2008) Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics.
71. Albina JE, Mills CD, Barbul A, Thirkill CE, Henry WL Jr , et al. (1988) Arginine metabolism in wounds. American Journal of Physiology 254: E459-467.
72. Efron DT, Barbul A (2003) Subcutaneous sponge models. Methods in Molecular Medicine 78: 83-93.
73. Schaffer MR, Tantry U, Barbul A (2004) Wound fluid inhibits wound fibroblast nitric oxide synthesis. Journal of Surgical Research 122: 43-48.
74. Depraetere V (2000) "Eat me" signals of apoptotic bodies. Nat Cell Biol 2: E104.
75. Devitt A, Gregory CD (2004) Measurement of apoptotic cell clearance in vitro. Methods Mol Biol 282: 207-221.
76. Underwood RA, Gibran NS, Muffley LA, Usui ML, Olerud JE (2001) Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. Journal of Histochemistry & Cytochemistry 49: 1285-1291.
77. Matalka KZ, Tutunji MF, Abu-Baker M, Abu Baker Y (2005) Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines. Neuroendocrinology Letters 26: 231-236.
78. Khanna S, Roy S, Park HA, Sen CK (2007) Regulation of c-SRC activity in glutamate-induced neurodegeneration. J Biol Chem Jun 14; [Epub ahead of print].
79. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, et al. (2003) Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res 92: 264-271.
80. Roy S, Khanna S, Rink T, Radtke J, Williams WT, et al. (2007) P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Molecular Biology of the Cell 18: 4837-4846.